Is Now the Time to Buy Cannabis Stocks?

Bearish sentiment is at a year-low and stocks such as Canopy Growth Crop (TSX:WEED)(NYSE:CGC) are well off their highs. Should you buy while others are fearful?

| More on:
question marks written reminders tickets

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

It hasn’t been a great year for those invested in the cannabis sector. Year to date, the Canadian Marijuana Index is down 15% and has been in a steady downtrend since February. The Index hasn’t been this low since the industry experienced strong tailwinds in late 2017.

It’s been almost two years and long-term investors are averaging negative returns. So why is this sector that holds so much promise underperforming the broader TSX Index?

It’s simple: bad news has dominated the headlines. Here are but a few of the newsworthy items that have plagued the sector:

  • CannTrust (TSX:TRST)(NYSE:CTST) was caught with illegal growing operations. To make matters worse, it appears that they intentionally mislead Health Canada officials, and high-level officials have now been accused of insider trading. This saga is still playing out and its assets may be sold for pennies on the dollar.
  • Canopy Growth Corp (TSX:WEED)(NYSE:CGC) suddenly dismissed CEO and co-founder Bruce Linton in early July.
  • Aphria (TSX:APHA)(NYSE:APHA) was caught up in a scandal in late 2018 in which a short seller accused the company of engaging in takeovers that are essentially worthless —  all in the name of lining insider pockets. This led to an investigation, the ousting of former CEO Vic Neufield and co-founder Cole Cacciavillani and a write-down of assets.

Regardless of your opinion on any of these individual companies, there is no denying that each situation has clouded the entire cannabis industry.

If you notice, all these scandals have one thing in common – poor governance. This isn’t surprising.

Every year, the Report on Business releases its annual evaluation of Canada’s corporate boards (Board Games). In its annual review released last November, it analyzed the governing practices of 237 TSX-listed companies. Where did Canada’s largest pot stocks rank?

Aphria ranked 227th and Canopy Growth Corp came in second to last. Who came in dead last? That would be Aurora Cannabis (TSX:ACB)(NYSE:ACB). Interestingly, those which rank in the lower tier tend to be among the TSX’s laggards.

The most recent Board Games report was a warning shot across the bow. Given all the recent governance issues, the market is beginning to take notice – good corporate governance is important.

Rhaul Bhardwaj, CEO of the Institute of Corporate Directors said it best:

“You might be able to get away with less than tier-one corporate governance for a while, but it would be unwise to wait for your stock price to drop and the market tell you your corporate governance practices aren’t up to snuff, because now you’re dealing with it in the vacuum of a crisis.”

Sound familiar? This is exactly the situation many of the industry leaders now find themselves in.

Despite all the negativity surrounding the industry, it still shows much promise. Now trading near multi-year lows, it may be the time to take advantage of overly bearish sentiment.

Prices have come down considerably, and the recent downtrend may prove to be an excellent entry point.

Keep in mind however, that this is still an industry in its infancy and is a speculative play at best. This isn’t a sector you dump your retirement money into. If however, you do have spare investment funds kicking around, it may be worth a gamble.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Mat Litalien holds no position in any of the companies mentioned. 

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »